References
Cavaillon JM, Adrie C, Fitting C Adib-Conquy M (2005) Reprogramming of circulatory cells in sepsis and SIRS. J Endotoxin Res 11:311–320
Cohen J (2002) The immunopathogenesis of sepsis. Nature 420:885–891
Cavaillon JM (2002) “Septic plasma”: an immunosuppressive milieu. Am J Respir Crit Care Med 166:1417–1418
Bone RC (1996) Sir Isaac Newton, sepsis, SIRS, and CARS. Crit Care Med 24:1125–1128
Munford RS, Pugin J (2001) Normal responses to injury prevent systemic inflammation and can be immunosuppressive. Am J Respir Crit Care Med 163: 316–321
Volk HD, Reinke P, Docke WD (2000) Clinical aspects: from systemic inflammation to 'immunoparalysis'. Chem Immunol 74:162–177
Pangault C, Le Tulzo Y, Tattevin P, Guilloux V, Bescher N, Drenou B (2006) Down-modulation of granulocyte macrophage-colony stimulating factor receptor on monocytes during human septic shock. Crit Care Med 34:1193–1201
Le Tulzo Y, Pangault C, Amiot L, Guilloux V, Tribut O, Arvieux C, Camus C, Fauchet R, Thomas R, Drenou B (2004) Monocyte human leukocyte antigen-DR transcriptional downregulation by cortisol during septic shock. Am J Respir Crit Care Med 169:1144–1151
Pachot A, Monneret G, Brion A, Venet F, Bohe J, Bienvenu J, Mougin B, Lepape A (2005) Messenger RNA expression of major histocompatibility complex class II genes in whole blood from septic shock patients. Crit Care Med 33:31–38 discussion 236–237
Fumeaux T, Pugin J (2002) Role of interleukin-10 in the intracellular sequestration of human leukocyte antigen-DR in monocytes during septic shock. Am J Respir Crit Care Med 166:1475–1482
Nierhaus A, Montag B, Timmler N, Frings DP, Gutensohn K, Jung R, Schneider CG, Pothmann W, Brassel AK, Schulte Am Esch J (2003) Reversal of immunoparalysis by recombinant human granulocyte-macrophage colony-stimulating factor in patients with severe sepsis. Intensive Care Med 29:646–651
Docke WD, Randow F, Syrbe U, Krausch D, Asadullah K, Reinke P, Volk HD, Kox W (1997) Monocyte deactivation in septic patients: restoration by IFN-gamma treatment. Nat Med 3:678–681
Nakos G, Malamou-Mitsi VD, Lachana A, Karassavoglou A, Kitsiouli E, Agnandi N, Lekka MF (2002) Immunoparalysis in patients with severe trauma and the effect of inhaled interferon-gamma. Crit Care Med 30:1488–1494
Spittler A, Roth E (2003) Is monocyte HLA-DR expression predictive for clinical outcome in sepsis? Intensive Care Med 29:1211–1212
Tschoeke SK, Moldawer LL (2005) Human leukocyte antigen expression in sepsis: what have we learned? Crit Care Med 33:236–237
Monneret G, Lepape A, Voirin N, Bohé J, Venet F, Debard AL, Thizy H, Bienvenu J, Gueyffier F, Vanhems P (2006) Intensive Care Med DOI 10.1007/s00134–0204-8
Docke WD, Hoflich C, Davis KA, Rottgers K, Meisel C, Kiefer P, Weber SU, Hedwig-Geissing M, Kreuzfelder E, Tschentscher P, Nebe T, Engel A, Monneret G, Spittler A, Schmolke K, Reinke P, Kunz D (2005) Monitoring temporary immunodepression by flow cytometric measurement of monocytic HLA-DR expression: a multicenter standardized study. Clin Chem 51:2341–2347
Monneret G, Elmenkouri N, Bohe J, Debard AL, Gutowski MC, Bienvenu J, Lepape A (2002) Analytical requirements for measuring monocytic human lymphocyte antigen DR by flow cytometry: application to the monitoring of patients with septic shock. Clin Chem 48:1589–1592
Author information
Authors and Affiliations
Corresponding author
Additional information
This editorial refers to the article available at: http://dx.doi.org/10.1007/s00134-006-0204-8
Rights and permissions
About this article
Cite this article
Fumeaux, T., Pugin, J. Is the measurement of monocytes HLA-DR expression useful in patients with sepsis?. Intensive Care Med 32, 1106–1108 (2006). https://doi.org/10.1007/s00134-006-0205-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00134-006-0205-7